Found 5 matching trials
Phase 1 Study to Evaluate the Safety and Immunogenicity of a Candidate Vaccine Against Respiratory Syncytial Virus
PHASE1The primary and secondary objectives of this Phase 1 study are respectively...
Location
Centre for Vaccinology (CEVAC)
A Study to Evaluate the Safety and Reactogenicity of DPX-RSV(A), a Respiratory Syncytial Virus Vaccine
PHASE1Administration of DPX-RSV(A), a Respiratory Syncytial Virus vaccine contain...
Location
IWK Health Centre
RSV F Dose-Ranging Study in Women
PHASE2The purpose of this study is to evaluate the immunogenicity and safety of m...
Location
Diablo Clinical Research
First-in-human Safety and Immunogenicity Study of SCB-1019 and SCB-1019T in Healthy Adults
PHASE1First-in-human Safety and Immunogenicity Study of SCB-1019 and SCB-1019T in...
Location
Fusion Clinical Research
Evaluation of RSV/Flu-01E Vaccine for the Prevention of RSV Infection in Volunteers Aged 18 to 59 Years and Over 60 Years
PHASE1The aim of the study is to investigate the safety and immunogenicity of the...
Location
Smorodintsev Research Institute of Influenza